THOUSAND OAKS, Calif., May 30, 2023 /PRNewswire/ -- Amgen (AMGN) today announced new research examining the use of Otezla ® (apremilast) in psoriatic arthritis, including the Phase 4 MOSAIC study and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback